Literature DB >> 27558584

BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics.

Louise Hamilton1, Nick Barkham2, Ashok Bhalla3, Robin Brittain4, Debbie Cook5, Gareth Jones6, Kirsten Mackay7, David Marshall8, Helena Marzo-Ortega9, Daniel Murphy10, Claire Riddell11, Raj Sengupta3, Stefan Siebert12, Liz Van Rossen13, Karl Gaffney14.   

Abstract

Entities:  

Keywords:  ankylosing spondylitis; anti-TNF; axial spondyloarthritis; biologic; guideline; treatment

Mesh：

Substances：

Year:  2016        PMID： 27558584     DOI： 10.1093/rheumatology/kew223

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  9 in total

Review 1.  New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice.

Authors:  Sayam Dubash; Dennis McGonagle; Helena Marzo-Ortega
Journal:  Ther Adv Chronic Dis       Date:  2017-12-14       Impact factor: 5.091

Review 2.  The current standard of care and the unmet needs for axial spondyloarthritis.

Authors:  Basil Noureldin; Nick Barkham
Journal:  Rheumatology (Oxford)       Date:  2018-08-01       Impact factor: 7.580

3.  Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK.

Authors:  Paul Emery; Marjolijn Van Keep; Steve Beard; Chris Graham; LaStella Miles; Steffen Marc Jugl; Praveen Gunda; Anna Halliday; Helena Marzo-Ortega
Journal:  Pharmacoeconomics       Date:  2018-08       Impact factor: 4.981

4.  Exploring sub-optimal response to tumour necrosis factor inhibitors in axial spondyloarthritis.

Authors:  Fariz Yahya; Karl Gaffney; Raj Sengupta
Journal:  Rheumatol Adv Pract       Date:  2019-05-04

Review 5.  The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus.

Authors:  Eun-Jung Park; Hyungjin Kim; Seung Min Jung; Yoon-Kyoung Sung; Han Joo Baek; Jisoo Lee
Journal:  Korean J Intern Med       Date:  2020-01-02       Impact factor: 2.884

Review 6.  Taiwan Rheumatology Association consensus recommendations for the management of axial spondyloarthritis.

Authors:  James Cheng-Chung Wei; Chin-Hsiu Liu; Jui-Cheng Tseng; Lin-Fen Hsieh; Chun-Hsiung Chen; Hsin-Hua Chen; Hung-An Chen; Ying-Chou Chen; Chung-Tei Chou; Hsien-Tzung Liao; Yi-Chun Lin; Shue-Fen Luo; Deng-Ho Yang; Kai-Jieh Yeo; Wen-Chan Tsai
Journal:  Int J Rheum Dis       Date:  2019-11-27       Impact factor: 2.454

7.  Is There a Correlation Between Patient-Reported Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Score and MRI Findings in Axial Spondyloarthropathy in Routine Clinical Practice?

Authors:  Swetha Byravan; Nibha Jain; Jenna Stairs; Winston Rennie; Arumugam Moorthy
Journal:  Cureus       Date:  2021-11-16

Review 8.  Defining the target: clinical aims in axial spondyloarthritis.

Authors:  Helena Marzo-Ortega; Katie M Gaffney; Karl Gaffney
Journal:  Rheumatology (Oxford)       Date:  2018-08-01       Impact factor: 7.580

9.  Real-world evidence for subcutaneous infliximab (CT-P13 SC) treatment in patients with ankylosing spondylitis during the coronavirus disease (COVID-19) pandemic: A case series.

Authors:  Sooraj Vijayan; Kyungmin Hwangbo; Nick Barkham
Journal:  Clin Case Rep       Date:  2022-01-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.